Skip to main content
James McKinnell, MD, Infectious Disease, Torrance, CA

James Alexander McKinnell MD


Assistant Professor, Medicine, University of California Los Angeles David Geffen SOM

Join to View Full Profile
  • 2841 Lomita BlvdSuite 135Torrance, CA 90501

  • Phone+1 310-784-6954

Dr. McKinnell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. James McKinnell is an infectious disease specialist based in Torrance, California. He completed his fellowship in Infectious Disease from the University of Alabama Medical Center in 2009 and his residency in Internal Medicine at the Los Angeles County-Harbor-UCLA Medical Center in 2007. Dr. McKinnell has over 80 publications in reputable medical journals like the New England Journal of Medicine and Clinical Infectious Diseases. Dr. McKinnell is past President of the Infectious Disease Association of California (IDAC) and still serves on the IDAC Board of Directors.

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Infectious Disease, 2007 - 2009
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2004 - 2007
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • AL State Medical License
    AL State Medical License 2007 - 2009
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • FDA Approves Drug Combination for Complicated Intra-Abdominal Infections
    FDA Approves Drug Combination for Complicated Intra-Abdominal InfectionsFebruary 14th, 2025
  • AbbVie Scores FDA Nod for Pfizer-Partnered Antibiotic Emblaveo
    AbbVie Scores FDA Nod for Pfizer-Partnered Antibiotic EmblaveoFebruary 10th, 2025
  • Remember Overwhelmed Hospitals Across the US Three Years Ago?
    Remember Overwhelmed Hospitals Across the US Three Years Ago?January 28th, 2021
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: